Granules India Limited (NSE:GRANULES)

India · Delayed Price · Currency is INR

567.70

-6.70 (-1.17%)

Mar 5, 2026, 10:00 AM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Products	44.82B	45.06B	45.12B	37.65B	32.38B
Pharmaceutical Products Growth	-0.55%	-0.12%	19.84%	16.29%	24.59%
Total	44.82B	45.06B	45.12B	37.65B	32.38B
Total Growth	-0.55%	-0.12%	19.84%	16.29%	24.59%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	2.71B	2.26B	2.90B	4.56B	4.53B
India Growth	20.06%	-22.09%	-36.55%	0.68%	16.28%
Outside India	42.11B	42.81B	42.22B	33.09B	-
Outside India Growth	-1.64%	1.38%	27.62%	-	-
North America	-	-	-	-	17.48B
North America Growth	-	-	-	-	26.94%
Europe	-	-	-	-	5.83B
Europe Growth	-	-	-	-	18.03%
Latin America	-	-	-	-	2.91B
Latin America Growth	-	-	-	-	40.16%
ROW	-	-	-	-	1.94B
ROW Growth	-	-	-	-	49.50%
Total	44.82B	45.06B	45.12B	37.65B	32.70B
Total Growth	-0.55%	-0.12%	19.84%	15.14%	25.83%

Source: S&P Global Market Intelligence.